Nosocomial Pneumonia
Strategies for Management
Samenvatting
This multi–contributed text, co–ordinated by one of the leading authorities in the field, is a unique resource to cover in depth the management of the important issue of Nosocomial Pneumonia in respiratory medicine and critical care. This disease presents the clinician with a variety of challenges, in both diagnosis and management, all of which represent a significant concern for the welfare of patients whose ability to combat infection is frequently already compromised.
Nosocomial Pneumonia: Strategies for Management is dedicated specifically to this most common hospital acquired respiratory infection and reviews important new advances in therapeutics, including drug resistance. It is an essential resource for all postgraduates and specialist physicians in pulmonology and infectious diseases.
Specificaties
Inhoudsopgave
<p>List of Contributors.</p>
<p>Abbreviations.</p>
<p>1. Health Care Associated–Pneumonia: Epidemiology, Microbiology and Clinical Outcomes (Dr. Marcos I. Restrepo and Dr. Antonio Anzuelo, San Antonio, Texas. US).</p>
<p>2. Prevention of Hospital–Acquired Pneumonia (Dr. Rafael Sierra and Antonio Gordillo, Cádiz, Spain).</p>
<p>3. Role of the microbiology laboratory in the diagnosis of ventilator–associated pneumonia (Dr. Emilio Bouza, Dra. Almudena Burillo, Dra. Patricia Muñoz, Madrid, Spain).</p>
<p>4. Pathophysiology of Pneumonia (Dra Amalia Alcón, Dr. Mauricio Valencia, Dr. Antoni Torres, Barcelona, Spain).</p>
<p>5. Clinical approach to the patient with HAP (Dr. Jordi Rello, Tarragona, Spain & Dr. Miguel Gallego, Sabadell, Spain).</p>
<p>6. Pneumonia due to Pseudomonas aeruginosa (Dr. Jordi Vallés and Dra. Dolors Marisca, Sabadell. Spain).</p>
<p>7. Hospital acquired–pneumonia caused by Staphylococcus aureus (Dra. Despoina Koulenti, Athens, Greece; Dr. Kemal Agbaht, Ankara, Turkey).</p>
<p>8. Nosocomial pneumonia by Acinetobacter baumannii (Dr. José Garnacho–Montero and Da. Eugenia Pachón, Dr. J.M. Cisneros, Sevilla, Spain).</p>
<p>9. Fungal pneumonia (Dr. George Dimopoulos, Dr. E. Papadomichelakis, Dr. P. Kopteridis, Athens, Greece).</p>
<p>10. General pharmacologic considerations and dose adjustment in antibiotic therapy for HAP (Dr. Pierluigi Viale and Dr. Federico Pea, Udine, Italy).</p>
<p>11. Minimally Invasive Diagnostic Strategy in Immunocompromized Patients with Pulmonary Infiltrates (Dra. Sandra. De Miranda and Dra. Élie Azoulay, Paris, France).</p>
<p>12. Pneumonia in trauma patients (Dra. Helene A. Haeberle and Dr. Wolfgang A. Krueger, Tubingen. Germany).</p>
<p>13. Acute Respiratory Distress Syndrome and pneumonia (Dr. Jean Chastre, Dr. Charles–Edouard Luyt, Dr. Jean Louis Trouillet, Dr. Alain Combes, Paris, France).</p>
<p>14. Assessment of patients with poor resolution of Hospital Acquired Pneumonia (Dr. Richard G. Wunderink, Dr. Keenan A. Hawkins, Chicago, USA).</p>
<p>15. Approach to Patients with recurrent VAP (Dr. Grant W. Waterer, Perth, Australia; Dr. Diego López. Madrid. Spain).</p>
<p>16. Costs for Hospital–Acquired Pneumonia & Ventilator–Associated Pneumonia (Dr. Andrew F. Shorr and Dr. William L. Jackson, Washington, USA).</p>
<p>Index.</p>